These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27067285)

  • 1. DHEA supplementation and ICSI outcomes: was this really randomized trial?
    Haydardedeoglu B
    Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():217. PubMed ID: 27067285
    [No Abstract]   [Full Text] [Related]  

  • 2. Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve?
    Kara M; Aydin T; Aran T; Turktekin N; Ozdemir B
    Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():63-5. PubMed ID: 24331115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dehydroepiandrosterone supplementation improves ovarian response and cycle outcome in poor responders.
    Sönmezer M; Ozmen B; Cil AP; Ozkavukçu S; Taşçi T; Olmuş H; Atabekoğlu CS
    Reprod Biomed Online; 2009 Oct; 19(4):508-13. PubMed ID: 19909591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of preconceptional DHEA treatment on in vitro fertilization outcome in poor ovarian respond women: study protocol for a randomized controlled trial.
    Wang W; Liu H; Li J; Wei D; Zhang J; Wang J; Ma J; Shi Y; Chen ZJ
    Trials; 2019 Jan; 20(1):50. PubMed ID: 30646929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dehydroepiandrosterone treatment in women with poor ovarian response undergoing IVF or ICSI: a systematic review and meta-analysis.
    Zhang M; Niu W; Wang Y; Xu J; Bao X; Wang L; Du L; Sun Y
    J Assist Reprod Genet; 2016 Aug; 33(8):981-91. PubMed ID: 27094195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does dehydroepiandrosterone improve pregnancy rate in women undergoing IVF/ICSI with expected poor ovarian response according to the Bologna criteria? A randomized controlled trial.
    Kotb MM; Hassan AM; AwadAllah AM
    Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():11-5. PubMed ID: 26963897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Authors' Response: DHEA supplementation and ICSI outcomes: was this really randomized trial?
    Kara M
    Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():217-8. PubMed ID: 27044620
    [No Abstract]   [Full Text] [Related]  

  • 8. DHEA use to improve likelihood of IVF/ICSI success in patients with diminished ovarian reserve: A systematic review and meta-analysis.
    Schwarze JE; Canales J; Crosby J; Ortega-Hrepich C; Villa S; Pommer R
    JBRA Assist Reprod; 2018 Nov; 22(4):369-374. PubMed ID: 30125071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression of cumulus cells in women with poor ovarian response after dehydroepiandrosterone supplementation.
    Tsui KH; Lin LT; Horng HC; Chang R; Huang BS; Cheng JT; Wang PH
    Taiwan J Obstet Gynecol; 2014 Dec; 53(4):559-65. PubMed ID: 25510701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis of dehydroepiandrosterone supplementation among women with diminished ovarian reserve undergoing in vitro fertilization or intracytoplasmic sperm injection.
    Li J; Yuan H; Chen Y; Wu H; Wu H; Li L
    Int J Gynaecol Obstet; 2015 Dec; 131(3):240-5. PubMed ID: 26421833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life.
    Barnhart KT; Freeman E; Grisso JA; Rader DJ; Sammel M; Kapoor S; Nestler JE
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3896-902. PubMed ID: 10566625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral antioxidants supplementation for women with unexplained infertility undergoing ICSI/IVF: randomized controlled trial.
    Youssef MA; Abdelmoty HI; Elashmwi HA; Abduljawad EM; Elghamary N; Magdy A; Mohesen MN; Abdella RM; Bar MA; Gouda HM; Ali AM; Raslan AN; Youssef D; Sherif NA; Ismail AI
    Hum Fertil (Camb); 2015 Mar; 18(1):38-42. PubMed ID: 24989721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dehydroepiandrosterone supplementation in elderly men: a meta-analysis study of placebo-controlled trials.
    Corona G; Rastrelli G; Giagulli VA; Sila A; Sforza A; Forti G; Mannucci E; Maggi M
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3615-26. PubMed ID: 23824417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of vitamin E and D
    Fatemi F; Mohammadzadeh A; Sadeghi MR; Akhondi MM; Mohammadmoradi S; Kamali K; Lackpour N; Jouhari S; Zafadoust S; Mokhtar S; Giahi L
    Clin Nutr ESPEN; 2017 Apr; 18():23-30. PubMed ID: 29132734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders.
    Yeung TW; Chai J; Li RH; Lee VC; Ho PC; Ng EH
    Fertil Steril; 2014 Jul; 102(1):108-115.e1. PubMed ID: 24796766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dehydroepiandrosterone supplementation in women undergoing assisted reproductive technology with poor ovarian response. A prospective case-control study.
    Al-Turki HA
    J Int Med Res; 2018 Jan; 46(1):143-149. PubMed ID: 28758852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism.
    Libè R; Barbetta L; Dall'Asta C; Salvaggio F; Gala C; Beck-Peccoz P; Ambrosi B
    J Endocrinol Invest; 2004 Sep; 27(8):736-41. PubMed ID: 15636426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of a Standardized Oral Multinutrient Supplementation on Embryo Quality in in vitro Fertilization/Intracytoplasmic Sperm Injection: A Prospective Randomized Trial.
    Nouri K; Walch K; Weghofer A; Imhof M; Egarter C; Ott J
    Gynecol Obstet Invest; 2017; 82(1):8-14. PubMed ID: 27832646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of dehydroepiandrosterone in postmenopausal women with fibromyalgia.
    Finckh A; Berner IC; Aubry-Rozier B; So AK
    J Rheumatol; 2005 Jul; 32(7):1336-40. PubMed ID: 15996074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WITHDRAWN: Dehydroepiandrosterone (DHEA) supplementation for cognitive function.
    Huppert FA; Van Niekerk JK
    Cochrane Database Syst Rev; 2007 Jul; 2006(2):CD000304. PubMed ID: 17636627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.